MedPath

Efficacy of Parasternal Blocks in Cardiovascular Surgery Patients Undergoing Median Sternotomy

Not Applicable
Recruiting
Conditions
Postoperative Pain
Interventions
Procedure: 1. no block
Procedure: 3. deep parasternal block
Procedure: 2. superficial parasternal block
Registration Number
NCT06387095
Lead Sponsor
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
Brief Summary

Acute and chronic pain after cardiac surgery is a common problem that negatively affects quality of life. Postoperative pain after cardiac surgery is most intense in the first two days and decreases in the following period. However, postoperative pain with incomplete management in the acute period may become chronic. This may negatively affect the patient's quality of life. Although central blocks such as thoracic epidural and paravertebral blocks are considered the gold standard in analgesia control, the advantages of thoracic plan blocks, which are more superficial due to peroperative heparinisation; coagulation disorders; and procedural difficulties, are undeniable. Thoracic plane blocks, which can also be used in patients receiving anticoagulant and/or antiplatelet therapy, have recently been used for acute pain. The aim of this study was to evaluate the effect of thoracic plane blocks on extubation time, pain scores, intensive care unit (ICU) and hospital stays in patients undergoing median sternotomy.

Detailed Description

The study will proceed in three arms. The first group is the control group and will receive total intravenous anaesthesia as infusion after peroperative induction until the patient leaves the operating room. The second group will receive ultrasound-guided parasternal superficial plan block after induction. The third group will receive ultrasound-guided parasternal deep plan block. Extubation times, additional analgesic needs, pain scores, intensive care unit duration and hospital discharge times will be compared in the three groups during intensive care unit follow-up. After extubation, patient-controlled analgesia will be applied for 24 hours (with pca infusion pump device).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Performing median sternotomy
  • Elective case
  • Over 18 years of age; under 80 years of age
  • ASA II-III patients
Exclusion Criteria
  • Emergency cases
  • Patients undergoing minimally invasive surgery
  • Patients with a history of opioid use in the last 30 days
  • Redo cases
  • Patients with left ventricular ejection fraction less than 30%
  • Patients with severe hepatic or renal insufficiency
  • Patients with chronic pain before surgery (migraine, fibromyalgia)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
1. control group1. no blockcontrol group. block will not be applied to this group and the patient's analgesia needs will be provided with patient-controlled analgesia devices.
3. deep parasternal plane block group3. deep parasternal blockdeep parasternal plane block group. deep paraasternal plane block will be applied to this group. it will be applied to the parasternal region with ultrasound after the patient is intubated. patient-controlled analgesia devices will be used for additional postoperative pain needs.
2. superficial parasternal plane block group2. superficial parasternal blocksuperficial parasternal plane block group. superficial paraasternal plane block will be applied to this group. it will be applied to the parasternal region with ultrasound after the patient is intubated. patient-controlled analgesia devices will be used for additional postoperative pain needs.
Primary Outcome Measures
NameTimeMethod
postoperative chronic pain6 months

Determination the effect of parasternal blocks on the incidence for chronic pain at 6 months postoperative period in cardiac surgery. The s-lanss scores of the patients at the 6th postoperative month will be evaluated. The range of the questionnaire is 0-24 and patients with a score above 12 will be considered to have neuropathic pain.

Secondary Outcome Measures
NameTimeMethod
icu time7 days

The study will look at whether intensive care and hospital discharge times differ between the groups.

extubation time24 hours

Extubation time (defined as the time from admission to intensive care unit until extubation) will be evaluated for differences between the groups.the control group

postoperative 24 hours acute pain24 hours

postoperative 24 hours pain of the patients will be evaluated with VAS (visual analogue scale). analgesic needs of the patients in the first 24 hours postoperatively will be calculated as morphine equivalent dose using PCA device. At the end of the 24th hour, BPI (brief pain index) will be evaluated. additional analgesic needs of the patients (NSAID, narcotic), if any, will be recorded. it will be evaluated whether there is a significant difference between the VAS scores, analgesic needs and BPI scores in the first 24 hours pain according to the groups.

Trial Locations

Locations (1)

Kosuyolu High Education and Training Hospital

🇹🇷

Istanbul, Kartal, Turkey

© Copyright 2025. All Rights Reserved by MedPath